Abstract
Opportunities for improved cervical cancer prevention have expanded in recent years with primary prevention by vaccination, new screening guidelines and new guidelines for the management of abnormal cervical screening tests and cancer precursors. Adoption requires an understanding of the data and rationale that has created major changes in what both clinicians and patients have come to expect. This session will review strategies for improving vaccine compliance and provide an overview of new screening guidelines, which increase benefit while decreasing harm for patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
